BusinessPrecipio Launches Unique Lung Cancer Monitoring Test for Therapy ResistanceBy Nasdaq OMXFeb 15, 2018, 1:38 PM UTC
BusinessExosome Diagnostics Publishes a Study Demonstrating Superior Performance of ExoLution™ Plus Liquid Biopsy Platform in Lung CancerBy Nasdaq OMXDec 19, 2017, 12:51 PM UTC
